R&D expenses increased 7.7% year-over-year mainly because of the development of new ECLIA reagents and FISH reagents. Sales and marketing expenses increased significantly year-over-year mainly due to ...

Good day, ladies and gentlemen and welcome to the Q3 2007 China Medical Technologies Incorporated earnings conference call. (Operator Instructions) I would now like to turn the call over to Ms. Winnie ...

Oxford Gene Technology (OGT), The Molecular Genetics Company, has announced that it is now directly selling Cytocell Fluorescence In Situ Hybridization (FISH) products through several established ...

The saga on the formalin-laced fish issue does not end. It just carries on, taking twists and turns, meandering along and arriving at no conclusion. There is ...